Get the Stockscreener App
245.21
0.09%
0.21
After Hours:
245.21
Overview
News
Price History
Option Chain
Financials
Why STE Down?
Discussions
Forecast
Stock Split
Dividend History
Steris Plc stock is traded at $245.21, with a volume of 1.04M.
It is up +0.09% in the last 24 hours and up +9.45% over the past month.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
See More
Previous Close:
$245.00
Open:
$243.32
24h Volume:
1.04M
Relative Volume:
1.62
Market Cap:
$24.09B
Revenue:
$5.46B
Net Income/Loss:
$614.64M
P/E Ratio:
39.55
EPS:
6.2
Net Cash Flow:
$778.00M
1W Performance:
+0.91%
1M Performance:
+9.45%
6M Performance:
+11.94%
1Y Performance:
+9.85%
1-Day Range:
$242.31
$245.69
1-Week Range:
$242.31
$247.24
52-Week Range:
$200.98
$252.79
Steris Plc Stock (STE) Company Profile
Name
Steris Plc
Sector
Industry
Phone
35312322000
Address
70 SIR JOHN ROGERSON'S QUAY, DUBLIN
Compare STE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STE
Steris Plc
|
245.21 | 23.87B | 5.46B | 614.64M | 778.00M | 6.20 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Steris Plc Stock (STE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-29-25 | Initiated | Jefferies | Hold |
| Oct-24-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| May-30-23 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-14-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-23-22 | Downgrade | Needham | Buy → Hold |
| Jul-14-22 | Initiated | Piper Sandler | Overweight |
| Apr-07-22 | Initiated | Wolfe Research | Outperform |
| May-26-21 | Upgrade | Needham | Hold → Buy |
| Feb-04-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-09-20 | Initiated | Needham | Hold |
| Jul-10-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-05-17 | Downgrade | Wellington Shields | Gradually Accumulate → Hold |
| May-03-17 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| Nov-30-16 | Initiated | Goldman | Neutral |
| Jun-03-16 | Upgrade | Northcoast | Neutral → Buy |
| Jun-12-15 | Downgrade | Raymond James | Strong Buy → Outperform |
| May-07-13 | Downgrade | Griffin Securities | Buy → Hold |
| Feb-08-13 | Reiterated | Griffin Securities | Buy |
| Aug-03-12 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Feb-08-12 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-03-11 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-09-11 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-21-10 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-17-10 | Initiated | JMP Securities | Mkt Outperform |
| Apr-07-10 | Reiterated | CL King | Strong Buy |
| Mar-26-10 | Initiated | CL King | Strong Buy |
| Mar-03-10 | Initiated | Brean Murray | Hold |
View All
Steris Plc Stock (STE) Latest News
Decoding Steris PLC (STE): A Strategic SWOT Insight - GuruFocus
Jefferies Initiates Coverage of Steris (STE) with ‘Hold’ Rating and $263 Price Target - MSN
Low Temperature Sterilization Equipment Market Set to Witness - openPR.com
Steris (STE) Receives 'Hold' Rating from Jefferies with $263 Pri - GuruFocus
Jefferies Initiates Coverage of STERIS (STE) with Hold Recommendation - Nasdaq
STERIS plc SEC 10-K Report - TradingView
Jefferies Initiates STERIS at Hold With $263 Price Target - marketscreener.com
Steris (STE) Faces Challenges Amid Healthcare Policy Shifts | ST - GuruFocus
Sterilization Monitoring Market Surges Towards USD 1.31 Billion by 2030 Amid Rising Demand for Real-Time Validation - GlobeNewswire Inc.
August 15th Options Now Available For STERIS - Nasdaq
STERIS Stock: Is Wall Street Bullish or Bearish? - MSN
STERIS Stock: Is Wall Street Bullish Or Bearish? - Barchart.com
Is it the Right Time to Hold STERIS Stock in Your Portfolio? - MSN
STERIS’s SWOT analysis: infection prevention leader’s stock faces challenges By Investing.com - Investing.com Canada
STERIS’s SWOT analysis: infection prevention leader’s stock faces challenges - Investing.com
STERIS plc (NYSE:STE) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
AST Business Growth & Strategic Acquisitions Support STERIS Stock - MSN
Cetera Investment Advisers Has $1.43 Million Holdings in STERIS plc (NYSE:STE) - Defense World
Are Options Traders Betting on a Big Move in STERIS (STE) Stock? - TradingView
Why Steris PLC (STE) Is Set to Outperform the Market: Insights i - GuruFocus
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Steris (STE) Target Price Raised by Morgan Stanley | STE Stock N - GuruFocus
Why Steris PLC (STE) Is Set to Outperform the Market: Insights into Financial Growth and Competitive Advantage - GuruFocus
Deciphering Steris (STE) International Revenue Trends - Yahoo Finance
Stephens Adjusts STERIS Price Target to $280 From $250, Maintains Overweight Rating - marketscreener.com
Steris outlines 6% to 7% revenue growth and $9.90–$10.15 EPS for fiscal 2026 amid tariff headwinds - MSN
STERIS stock target raised to $280 at Citizens JMP By Investing.com - Investing.com South Africa
Steris (STE) Price Target Raised by JMP Securities | STE Stock News - GuruFocus
Morgan Stanley Adjusts STERIS Price Target to $260 From $240 - marketscreener.com
STERIS plc (NYSE:STE) Q4 2025 Earnings Call Transcript - Insider Monkey
Steris (STE) Price Target Boosted to $280 by Citizens JMP | STE Stock News - GuruFocus
Piper Sandler Adjusts Price Target on STERIS to $280 From $265, Maintains Overweight Rating - marketscreener.com
STERIS stock target raised to $280 at Citizens JMP - Investing.com
STERIS Reports Strong Fiscal 2025 Results and Positive Outlook - TipRanks
Steris PLC (STE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook - Yahoo Finance
STERIS plc (Ireland) (STE) Stock Forecasts - Yahoo Finance
Steris Reports Strong Earnings Amid Challenges - TipRanks
STERIS Q4 2025 Earnings Call Transcript - MarketBeat
Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S. (NYSE:STE) - Seeking Alpha
U.S. Markets Closed Mixed Thursday As Steris Led, Fiserv Lagged - Barron's
Earnings call transcript: STERIS Beats Q4 2025 EPS Forecast, Stock Rises 5.9% - Investing.com Nigeria
STERIS (STE) Surpasses Q4 Revenue Expectations, Reports Record Year | STE Stock News - GuruFocus
Steris (STE) Retains Overweight Rating with Price Target of $250 - GuruFocus
Transcript : STERIS plc, Q4 2025 Earnings Call, May 15, 2025 - marketscreener.com
Steris (STE) Retains Overweight Rating with Price Target of $250 | STE Stock News - GuruFocus
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket - TradingView
Steris PLC Surpasses Q4 Estimates with $2.74 EPS and $1.5 Billio - GuruFocus
STERIS Announces Financial Results for Fiscal 2025 Fourth Quarter and Full Year - The Manila Times
Here's What Key Metrics Tell Us About Steris (STE) Q4 Earnings - Yahoo Finance
Steris (STE) Surpasses Q4 Earnings Estimates - Yahoo Finance
Steris Plc Stock (STE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):